Studying Blood Samples in Women With Breast Cancer or a History of Breast Cancer
NCT00898703 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2012-12-17
Summary
RATIONALE: Studying samples of blood in the laboratory from patients with current or previous cancer may help doctors learn more about biomarkers related to cancer.
PURPOSE: This research study is looking at blood samples in women with breast cancer or a history of breast cancer.
Conditions
Interventions
- OTHER
-
flow cytometry
- OTHER
-
immunoenzyme technique
- OTHER
-
laboratory biomarker analysis
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
University of Arizona
lead OTHER
Principal Investigators
-
Alison T. Stopeck, MD · University of Arizona
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-08-31
- Primary Completion
- 2007-03-31
- Completion
- 2007-03-31
Countries
- United States
Study Locations
More Related Trials
-
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
NCT01000883 ·Status: RECRUITING
-
Nutrition-Related Biomarkers in Predicting Breast Cancer Risk in Women
NCT00900367 ·Status: ACTIVE_NOT_RECRUITING
-
Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer
NCT00089323 ·Status: COMPLETED ·Phase: NA
-
Towards Early Detection of Breast Cancer in High Risk Population
NCT05268913 ·Status: UNKNOWN
-
A Multicenter Breast Cancer Biospecimen Registry
NCT02712645 ·Status: UNKNOWN
-
Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer
NCT00898014 ·Status: COMPLETED
-
Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer
NCT00897208 ·Status: COMPLETED
-
Molecular Analysis of Breast Cancer
NCT00569049 ·Status: COMPLETED
-
Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment
NCT02326857 ·Status: COMPLETED
-
Enabling the Study of Metabolism in Breast Cancer Through Collection of Fresh-tissue Biopsies
NCT03880097 ·Status: NOT_YET_RECRUITING
-
The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer
NCT06698679 ·Status: RECRUITING
-
Biomarkers in Native American Women With Breast Cancer
NCT00898976 ·Status: COMPLETED
-
A Biological Sample Collection Protocol of Women With and Without Breast Cancer
NCT00472589 ·Status: COMPLETED
-
Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification
NCT01839045 ·Status: UNKNOWN
-
Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer
NCT00766454 ·Status: COMPLETED
-
Study of Breast Tissue in Women Not Previously Diagnosed With Breast Cancer Who Are Undergoing Fine Needle Aspiration
NCT00896636 ·Status: UNKNOWN
-
Blood Sample Collection and Health Information Collection From Patients With Invasive Breast Cancer and Their Brothers and Sisters
NCT00445562 ·Status: UNKNOWN
-
Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831
NCT00898898 ·Status: COMPLETED
-
Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease
NCT00813878 ·Status: TERMINATED
-
Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI
NCT02587663 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in Blood Samples From Older Breast Cancer Survivors
NCT01138345 ·Status: COMPLETED
-
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
NCT00899301 ·Status: RECRUITING
-
Cell Lines From High-Risk Breast Tissue
NCT00032201 ·Status: COMPLETED
-
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
NCT00897065 ·Status: UNKNOWN
-
A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients
NCT00355316 ·Status: COMPLETED ·Phase: NA